Oklahoma 2024 Regular Session

Oklahoma House Bill HB2424 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	An Act
2		-	ENROLLED HOUSE
	1	+
	2	+
	3	+	SENATE FLOOR VERSION - HB2424 SFLR Page 1
	4	+	(Bold face denotes Committee Amendments) 1
	5	+	2
	6	+	3
	7	+	4
	8	+	5
	9	+	6
	10	+	7
	11	+	8
	12	+	9
	13	+	10
	14	+	11
	15	+	12
	16	+	13
	17	+	14
	18	+	15
	19	+	16
	20	+	17
	21	+	18
	22	+	19
	23	+	20
	24	+	21
	25	+	22
	26	+	23
	27	+	24
	28	+
	29	+	SENATE FLOOR VERSION
	30	+	April 13, 2023
	31	+
	32	+
	33	+	ENGROSSED HOUSE
3	34		BILL NO. 2424 By: May of the House
4	35
5	36		and
6	37
7	38		Stephens of the Senate
8		-
9		-
10	39
11	40
12	41
13	42
14	43		An Act relating to opioid antagonists; amending 63
15	44		O.S. 2021, Section 1 -2506.2, which relates to
16	45		prescription of opioid antagonists to family members;
17	46		replacing naloxone with opioid antagonist; amending
18	47		63 O.S. 2021, Section 2 -312.2, which relates to the
19	48		sale or dispensation of naloxone; removing naloxone
20	49		and replacing it with opioid antagonist; and
21	50		providing an effective d ate.
22	51
23	52
24	53
25	54
26		-	SUBJECT: Opioid antagonists
27		-
28	55		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
29		-
30	56		SECTION 1. AMENDATORY 63 O.S. 2021, Section 1 -2506.2, is
31	57		amended to read as follows:
32		-
33	58		Section 1-2506.2 A. Upon request, a provider may prescribe an
34	59		opiate opioid antagonist to an individual for use by that individual
35	60		when encountering a family member exhibiting signs of an opiate
36	61		opioid overdose.
37		-
38	62		B. When an opiate opioid antagonist is prescribed in accordance
39	63		with subsection A of this section, the provider shall provide:
40		-
41	64		1. Information on how to spot symptoms of an overdose;
42		-
43	65		2. Instruction in basic resuscitation techniques;
44	66
	67	+	SENATE FLOOR VERSION - HB2424 SFLR Page 2
	68	+	(Bold face denotes Committee Amendments) 1
	69	+	2
	70	+	3
	71	+	4
	72	+	5
	73	+	6
	74	+	7
	75	+	8
	76	+	9
	77	+	10
	78	+	11
	79	+	12
	80	+	13
	81	+	14
	82	+	15
	83	+	16
	84	+	17
	85	+	18
	86	+	19
	87	+	20
	88	+	21
	89	+	22
	90	+	23
	91	+	24
	92	+
45	93		3. Instruction on proper naloxone opioid antagonist
46		-	administration; and ENR. H. B. NO. 2424 Page 2
47		-
	94	+	administration; and
48	95		4. The importance of calling 911 nine-one-one (911) for help.
49		-
50	96		C. Any family member administering an opiate opioid antagonist
51	97		in a manner consistent with addressing opiate opioid overdose shall
52	98		be covered under the Good Samaritan Act.
53		-
54	99		D. Any provider prescribing o r administering an opiate opioid
55	100		antagonist in a manne r consistent with addressing opiate opioid
56	101		overdose shall be covered under the Good Samaritan Act.
57		-
58	102		SECTION 2. AMENDATORY 63 O.S. 2021, Section 2 -312.2, is
59	103		amended to read as follows:
60		-
61	104		Section 2-312.2 Naloxone, also known as Narcan , or any of its
62	105		generic equivalents Any opioid antagonist that is approved by the
63	106		United States Food and Drug Admini stration may be dispensed or sold
64	107		by a pharmacy without a prescription; provided, however, it shall be
65	108		dispensed or sold only by, or under t he supervision of, a licensed
66	109		pharmacist. Naloxone An opioid antagonist may be prescribed and
67	110		dispensed by a licens ed pharmacist; provided, however, it shall be
68	111		dispensed only by, or under the supervision of, a licensed
69	112		pharmacist. No dispensing protocol shall be required.
70		-
71	113		SECTION 3. This act shall become effective November 1, 2023.
72		-
73		-
74		-	ENR. H. B. NO. 2424 Page 3
75		-	Passed the House of Representati ves the 13th day of March, 2023.
76		-
77		-
78		-
79		-
80		-	Presiding Officer of the House
81		-	of Representatives
82		-
83		-
84		-	Passed the Senate the 19th day of April, 2023.
85		-
86		-
87		-
88		-
89		-	Presiding Officer of the Senate
90		-
91		-
92		-
93		-	OFFICE OF THE GOVERNOR
94		-	Received by the Office of the Governor this ____________________
95		-	day of ___________________, 20_______, at _______ o'clock _______ M.
96		-	By: _________________________________
97		-	Approved by the Governor of the State of Oklahoma this _____ ____
98		-	day of ___________________, 20_______, at _______ o'clock _______ M.
99		-
100		-
101		-	_________________________________
102		-	Governor of the State of Oklahoma
103		-
104		-	OFFICE OF THE SECRETARY OF STATE
105		-	Received by the Office of the Secretary of State this __________
106		-	day of ___________________, 20_______, at _______ o'clock _______ M.
107		-	By: _________________________________
	114	+	COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES
	115	+	April 13, 2023 - DO PASS